Your browser doesn't support javascript.
loading
Torasemide, but not frusemide, increases intracellular cAMP and cGMP content in the aorta of the renal hypertensive rat.
Yamanaga, K; Uchida, T; Kido, H; Hayashi, K; Watanabe, M.
Affiliation
  • Yamanaga K; Central Research Laboratory, Green Cross Corporation, Osaka, Japan.
J Pharm Pharmacol ; 44(1): 64-5, 1992 Jan.
Article in En | MEDLINE | ID: mdl-1350633
Repeated oral administration of the novel loop diuretic torasemide (3 mg kg-1) and frusemide (30 mg kg-1) for 7 days, elicited a significant fall in the systolic blood pressure in the one-kidney, one-clip Goldblatt renal hypertensive rat (RHR). The hypotensive action was greater in the torasemide group than in the frusemide group. Furthermore torasemide increased intracellular cAMP and cGMP content in aorta of RHR. Frusemide caused no effect. It is hypothesized that the increase in adenosine- or guanosine-nucleotides is involved in the antihypertensive action of torasemide, but not in that of frusemide.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Cyclic AMP / Cyclic GMP / Diuretics / Furosemide / Hypertension, Renovascular Limits: Animals Language: En Journal: J Pharm Pharmacol Year: 1992 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Cyclic AMP / Cyclic GMP / Diuretics / Furosemide / Hypertension, Renovascular Limits: Animals Language: En Journal: J Pharm Pharmacol Year: 1992 Document type: Article Affiliation country: Japan Country of publication: United kingdom